Area of research
Molecular Biology · Cancer Research
Research interest
Research focused on Cancer research and Sorafenib, with related work in Protein kinase B, PTEN, microRNA. Notable publications include 'LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells', 'Super-enhancer–driven EFNA1 fuels tumor progression in cervical cancer via the FOSL2-Src/AKT/STAT3 axis', and 'MicroRNA-582 promotes tumorigenesis by targeting phosphatase and tensin homologue in colorectal cancer'.
Super-enhancer–driven EFNA1 fuels tumor progression in cervical cancer via the FOSL2-Src/AKT/STAT3 axis
MiR-184 Mediated the Expression of ZNF865 in Exosome to Promote Procession in the PD Model
Targeting a novel circITCH/miR-421/BTG1 axis is effective to suppress the malignant phenotypes in hepatocellular carcinoma (HCC) cells
Circular RNA ITCH increases sorafenib-sensitivity in hepatocellular carcinoma via sequestering miR-20b-5p and modulating the downstream PTEN-PI3K/Akt pathway
LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
MicroRNA-582 promotes tumorigenesis by targeting phosphatase and tensin homologue in colorectal cancer
Intestinal bacterium-derived cyp27a1 prevents colon cancer cell apoptosis.
PubMed 2016cited by 6position: middle